IL30168A - Antigen-free vaccine and process for preparing it - Google Patents

Antigen-free vaccine and process for preparing it

Info

Publication number
IL30168A
IL30168A IL30168A IL3016868A IL30168A IL 30168 A IL30168 A IL 30168A IL 30168 A IL30168 A IL 30168A IL 3016868 A IL3016868 A IL 3016868A IL 30168 A IL30168 A IL 30168A
Authority
IL
Israel
Prior art keywords
vaccine
antigen
informationally
active
free
Prior art date
Application number
IL30168A
Other languages
English (en)
Other versions
IL30168A0 (en
Original Assignee
Jachertz D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jachertz D filed Critical Jachertz D
Publication of IL30168A0 publication Critical patent/IL30168A0/xx
Publication of IL30168A publication Critical patent/IL30168A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL30168A 1967-06-19 1968-06-12 Antigen-free vaccine and process for preparing it IL30168A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEJ0033936 1967-06-19

Publications (2)

Publication Number Publication Date
IL30168A0 IL30168A0 (en) 1968-08-22
IL30168A true IL30168A (en) 1973-05-31

Family

ID=7204943

Family Applications (1)

Application Number Title Priority Date Filing Date
IL30168A IL30168A (en) 1967-06-19 1968-06-12 Antigen-free vaccine and process for preparing it

Country Status (13)

Country Link
AT (1) AT282821B (ja)
BE (1) BE716806A (ja)
BR (1) BR6899970D0 (ja)
CH (1) CH513241A (ja)
DE (1) DE1617545C2 (ja)
DK (1) DK119724B (ja)
ES (1) ES355121A1 (ja)
FR (2) FR1588820A (ja)
GB (1) GB1229888A (ja)
IE (1) IE32140B1 (ja)
IL (1) IL30168A (ja)
NL (1) NL6808486A (ja)
NO (1) NO124840B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754934A (fr) * 1969-08-16 1971-02-17 Jachertz Diether Procede de production enzymatique d'arn-messager
GB1594097A (en) 1976-12-16 1981-07-30 Int Inst Of Differentiation Production of specific immune nucleic acids cell dialysates and antibodies
DE3115559A1 (de) * 1981-04-16 1982-10-28 Kommanditgesellschaft Schwarzhaupt, 5000 Köln Hochgereinigte informatorische ribonukleinsaeure (i-rns), verfahren zur herstellung und verwendung derselben
GB2216416B (en) * 1988-03-11 1992-06-24 Sandoz Ltd Nucleobase source for the stimulation of the immune system
US6867195B1 (en) 1989-03-21 2005-03-15 Vical Incorporated Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected
US6214804B1 (en) 1989-03-21 2001-04-10 Vical Incorporated Induction of a protective immune response in a mammal by injecting a DNA sequence
US6673776B1 (en) 1989-03-21 2004-01-06 Vical Incorporated Expression of exogenous polynucleotide sequences in a vertebrate, mammal, fish, bird or human
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery

Also Published As

Publication number Publication date
IL30168A0 (en) 1968-08-22
FR1588820A (ja) 1970-03-16
DE1617545A1 (de) 1971-04-01
CH513241A (de) 1971-09-30
DK119724B (da) 1971-02-15
DE1617545C2 (de) 1983-11-03
NL6808486A (ja) 1968-12-20
AT282821B (de) 1970-07-10
NO124840B (ja) 1972-06-12
BE716806A (ja) 1968-12-19
BR6899970D0 (pt) 1973-02-13
ES355121A1 (es) 1969-11-16
IE32140L (en) 1968-12-19
GB1229888A (ja) 1971-04-28
FR7781M (ja) 1970-03-23
IE32140B1 (en) 1973-04-18

Similar Documents

Publication Publication Date Title
JPH01125328A (ja) 髄膜炎菌ワクチン
NO309675B1 (no) Kombinert vaksine omfattende hepatitt B-overflateantigen
JPS61200924A (ja) 合成免疫原
CN106999569B (zh) 肠道病毒灭活的改进的方法、佐剂吸附及其获得的剂量减少的疫苗组合物
Olsen et al. Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus
WO2012093406A2 (en) A combination heptavalent vaccine
US4567041A (en) Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
UA119244C2 (uk) Бактеріальна вакцина і спосіб її одержання
RU2447898C2 (ru) Вакцина ipv-dpt
IL30168A (en) Antigen-free vaccine and process for preparing it
US3562387A (en) Mink virus enteritis vaccine and method for the production thereof
AU774649B2 (en) Vaccine preparations containing attenuated toxin
US3318775A (en) Production of viral antigens with n-acetyl-ethyleneimine
Nair et al. A comparative study of the immune responses of sheep against foot-and-mouth disease virus types Asia-1 and O PEG-concentrated aluminium hydroxide gel and oil-adjuvanted vaccines
JPH0341034A (ja) ネコ科動物感染性腹膜炎ワクチン
George et al. Route‐Related Variation in the Immunogenicity of Killed Salmonella enteritidis Vaccine: Role of Antigen Presenting Cells
US7615226B2 (en) Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant
Beck Review of studies with inactivated rubella virus
RU2712750C1 (ru) Амилоидный конъюгат, его применения и способы
US11213579B2 (en) Vaccines with enhanced immunogenicity, low allergenicity and reactogenicity
US3183161A (en) Aqueous resuspension vaccine product of aluminum phosphate-adsorbed poliomyelitis virus antigen, and production process
Sahu et al. Vaccines and sera
US3097143A (en) Myristyl-gamma-picolinium chloride preserved polio vaccine and its production
RU2148412C1 (ru) Способ получения протективного коклюшного антигена
US20220313816A1 (en) Compositions and methods for antibody-as-adjuvant vaccines and therapeutics